Fundraising FoxNovalis LifeSciences
Venture capitalPortsmouth · Seed–Late Stage · 9 people tracked
Find your way into Novalis LifeSciences
395 people in our graph share verified history with the Novalis LifeSciences team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Novalis Advisory provides strategic advisory and investment banking services, including consulting on business organization and operations, financial and management matters, and executive and leadership development training and coaching.
Source: firm website, verified Aug 3, 2026.
Team · 9 people
from the firm's website & public directories
What they invest in
from 26 of 27 portfolio companiesBiotech ×17Healthtech ×12Medical Devices ×12AI & Machine Learning ×11Deep Tech ×11Hardware ×5AgTech ×4Digital Health ×4
HQs:United States×21Belgium×1
Investments · 27 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 22024 · 12023 · 12022 · 62021 · 22020 · 42019 · 12017 · 119 dated
Quanterix develops technology for highly sensitive detection of protein biomarkers using non-invasive sample types, aimed at early disease detection and prevention.
BiotechDigital HealthHealthtechMedical DevicesLexington, US
David Walt(Director)inErnest Orticerio(Executive Officer)Ernest Oriticerio(Executive Officer)Masoud Toloue(Former Chief Executive Officer)in
BoardJohn Connolly(Director)inKeith Crandell(Director)
Board seatMarijn DekkersPaul Meister· per SEC Form D · $6.5M raise · filed Jul 2019
Co-investorsARCH Venture PartnersFoothill VenturesKhosla VenturesIn-Q-Tel
Ginkgo Bioworks builds autonomous labs that accelerate bioengineering for applications in pharmaceutical, agricultural, and industrial biotechnology.
AgTechAI & Machine LearningBiotechDeep TechHealthtechRoboticsBoston, US
Jason Kelly(Co-founder and CEO)inReshma Shetty(Co-founder; President, Chief Operations Officer)inBarry Canton(Co-founder)inAustin Che(Co-founder)inTom Knight(Founder; Ginkgo Fellow)inPeter Boynton(Director)
Co-investors11.2 CapitalAllen Institute for AI (AI2) IncubatorAzure Capital PartnersB3 HoldingBlue Owl CapitalCannage Capital+53 more
Animol is a biopharmaceutical company developing a proprietary pipeline of novel veterinary small-molecule drugs for both companion and farm animals, targeting areas from anti-parasitics to chronic diseases.
AgTechAI & Machine LearningBiotechDeep TechHealthtechBoston, US
Andrew Calabrese(Scientific Co-Founder)inAndrew Calabrese, Ph.D.(Scientific Co-Founder)Douglas E. Hutchens(CSO)inLogan Andrews(Head of Program Management)inPhilip Austin(Managing Partner, Anterra Capital; co-founder of Animol)inAndrew Plant(Executive Officer, Director)in
Board seatMarijn Dekkers· per SEC Form D
Co-investorsAnterra CapitalDYDX Capital
Activ Surgical develops intraoperative surgical intelligence technology for surgeons, using AR, AI, machine learning, and sensing to display physiological structures and functions not visible to the naked eye.
AI & Machine LearningHealthtechMedical DevicesBoston, US
Peter Kim(Director)inMichael Ruehlman(Executive Officer)inTodd Usen(Executive Officer, Director)in
BoardEmily Casey(Director)Ashok Krishnamurthi(Director)inDavid Wells(Director)
Board seatPaul Meister· per SEC Form D · $15M raise · filed Jul 2020
Co-investorsReimagined VenturesAlumni VenturesArtis VenturesBasecamp FundCastor VenturesCota Capital+8 more
US agricultural biotech that discovered microbe-based crop protection products; its assets were sold to Certis Biologicals and Ginkgo Bioworks in 2024.
AgTechResearch Triangle Park, US
Scott Uknes(Manager)inEric Ward(Manager)Paul Schulze-Lefert(President)Michael Koziel(Vice President and Manager)
BoardThomas Dietz(Manager)Kristina Burow(Manager)in
Board seatMarijn Dekkers· per SEC Form D
Co-investorsAliment CapitalBlue Horizon CorporationPontifax AgTechARCH Venture PartnersBill & Melinda Gates FoundationLeaps by Bayer+1 more
BlueWhale Bio develops manufacturing technologies for cell-based therapies, focusing on cell activation and expansion in early-stage processing to improve efficiency and reduce costs.
BiotechDeep TechMedical DevicesPhiladelphia, US
Peter Keller(Executive Officer, Director)in
BoardElaine Heron(Director)Paula Cannon(Director)Beate Mueller-Tiemann(Director)
Board seatPaul Meister· per SEC Form D
Co-investorsAscendo VenturesBaselayer CapitalCardanoGhaf Capital Partnersgumi IncPRIMAL CAPITAL+2 more
Everest Biolabs develops automated instruments, size-exclusion chromatography columns, and ELISA assays for extracellular vesicle (EV) isolation, concentration, and quantification.
BiotechDeep TechHardwareWaltham, US
George Daaboul(Executive Officer, Director)inDavid Freedman(Executive Officer, Director)
BoardVinit Nijhawan(Director)inDavid Walt(Director)
Board seatPaul Meister· per SEC Form D · $5.7M raise · filed Mar 2026
Co-investorsMassVentures
Flywheel provides a platform for organizing, managing, and sharing medical imaging data.
AI & Machine LearningData & InfrastructureHealthtechMedical DevicesMinneapolis, US
Brian Wandell(Co-founder)Gunnar Schaefer(Co-founder)inColby Moosman(Executive Officer)inMatthew D. Michela(Executive Officer, Director)inSarah Fazio(Executive Officer)Jim Olson(Executive Officer)in
Board seatMarijn DekkersPaul MeisterDevin Leake· per SEC Form D
Co-investors8VCBeringeaGreat North VenturesIntuitive VenturesiSelect FundLightbank+2 more
Early commercial stage company selling a real-time cell analyzer to pharma companies.
BiotechCharlottesville, US
Sean Hart(Executive Officer, Director)inRenee Hart(Executive Officer, Director)Robert Heiser(Director)Pete Buzy(Director)Dennis Walczewski(Director)Paul Meister(Director)
Board seatPaul Meister· per SEC Form D · $9.3M raise · filed Mar 2022
Co-investorsAsahi Kasei Corporate Venture Capital
Mercy BioAnalytics develops diagnostic tests for early cancer detection using advanced proteomics and genomics technologies.
BiotechDigital HealthHealthtechMedical DevicesNatick, US
Paul Blavin(Co-Founder & Vice Chairman)inStanley Lapidus(Director)inDawn Mattoon, PhD(Chief Executive Officer)Joseph Sedlak(Executive Officer, Director)
BoardSonja Hoel Perkins(Director)in
Board seatPaul Meister· per SEC Form D
Co-investorsAvestria VenturesHatteras Venture PartnersiSelect FundMindshift CapitalPortfoliaSozo Ventures+1 more
Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US
George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inRobert Carson(Executive Officer, Director)Terry Lo(Director)inSeth Benson(Executive Officer)inSimona Levi(Executive Officer)in
Board seatMarijn Dekkers· per SEC Form D · $37M raise · filed Apr 2021
Co-investorsARCH Venture PartnersM VenturesNorthpond VenturesIllumina Ventures
Enko discovers and develops novel crop protection products for farmers using a proprietary AI and machine learning discovery platform to combat pests and diseases.
AgTechAI & Machine LearningBiotech
Tom Meade(Chief Science Officer)
Co-investorsConnecticut InnovationsDYDX CapitalEndeavor8Germin8 VenturesAnterra CapitalEight Roads Ventures+1 more
Etherna is an RNA-LNP technology company that develops proprietary RNA chemistry and lipid nanoparticle delivery platforms for nucleic acid–based therapeutics, and partners with pharma and biotech organizations from early discovery through clinical development.
BiotechDeep TechMedical DevicesNiel, BE
Co-investorsFund+PMVBoehringer Ingelheim Venture FundEQT Life SciencesOmega FundsPWV
Flywheel provides a building operations platform for facility and property managers to manage maintenance teams, track preventative and ad hoc tasks, and analyze energy usage.
CleantechEnergyPropTechSaaSDallas, US
Steve Gossett, Jr.(CEO)Brian BezdekBrian Ratcliff
Co-investors8VCBraemar Energy VenturesNVIDIA
WP Engine (Flywheel) provides enterprise-grade WordPress hosting infrastructure designed to support high-traffic websites with advanced caching, security, and network optimization.
Cloud ComputingDeveloper ToolsSaaSAustin, US
Jason Cohen(Founder)
Co-investorsHyde Park Venture PartnersNelnet8VCCratonNVIDIA
LevitasBio develops label-free cell isolation and analysis technology for life science researchers, enabling higher-quality cell sample preparation without introducing bias or gene expression modifications.
BiotechDeep TechHardwareMedical Devices
Dr. Gozde Durmus(Co-founder)Dr. Utkan Demirci(Co-founder)Dr. Lars Steinmetz(Co-founder)
Co-investorsDecheng Capital
Ori develops expandable-unit technology for multifamily real estate, enabling hotel-to-housing conversions and ground-up developments that increase unit density while maintaining livability.
Construction TechHardwareImpact & Social GoodPropTech
Co-investorsIngka InvestmentsPresidio VenturesThe E14 FundAmadeus Capital PartnersDelin VenturesKhosla Ventures+3 more
ORI provides an integrated business planning platform for supply chain professionals, combining demand planning, S&OP, S&OE, data analytics, and long-term planning in one tool.
AI & Machine LearningLogistics & Supply ChainSaaS
Brant Slade(Founder)in
Co-investorsKickstartAmadeus Capital PartnersDelin VenturesKhosla VenturesNorthpond VenturesOctopus Ventures+2 more
Ori Biotech develops manufacturing automation platforms for cell and gene therapies, addressing scalability and cost barriers that limit patient access to these treatments.
Advanced ManufacturingBiotechDeep TechHardwareHealthtechMedical Devices
Co-investorsAmadeus Capital PartnersKindred CapitalDelin VenturesNorthpond VenturesOctopus VenturesPuhua Capital
Orogen Therapeutics uses AI and machine learning to accelerate drug discovery, focusing on small molecule candidates for immuno-inflammatory diseases.
AI & Machine LearningBiotechDeep TechMedical Devices
Mark Pykett(Chief Executive Officer)
HealthtechCambridge, US
Rahul Dhanda(Executive Officer, Director)inJames Collins(Director)David Walt(Director)in
BoardIssi Rozen(Director)in
Co-investorsCatalio Capital Management, LPIllumina VenturesCatalio Capital ManagementGood VenturesGV (Google Ventures)Northpond Ventures
SkylineDx develops gene-based diagnostic tests that identify how patients will respond to treatment by analyzing genomic alterations in disease cells, serving oncology and dermatology care providers and patients.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSan Diego, US
Telesis Bio, Inc. is a company whose corporate governance page describes its Board of Directors and governance practices.
AI & Machine LearningBiotechDeep TechHardwareHealthtechSan Diego, US
Daniel G. Gibson(Executive Officer)inTodd R. Nelson(Executive Officer, Director)Eric Esser(Executive Officer)inWilliam F. Snider(Director)Andrea L. Jackson(Director)inChristine A. Tsingos(Director)
Co-investorsNorthpond Ventures
BiotechDigital HealthHealthtechMedical DevicesMiami, US
Matthew H. J. Kim(Executive Officer, Director)
BoardTimothy Barabe(Director)Eric Stone(Director)Jonathan T. Lord(Director)Jeffrey Goodman(Director)
AIRNA develops genetic medicines that use ADAR, a naturally occurring human protein, to precisely edit RNA and treat genetic diseases without permanently modifying DNA.
AI & Machine LearningBiotechDeep TechHealthtechStanford, US
Thorsten Stafforst(Chairman of the Board of Directors)inKris ElveruminTodd Bazemore(Chief Executive Officer)inJin (Billy) Li(Treasurer and Secretary)inPaul Vogel(Chief Executive Officer and President)in
BoardRodger Novak(Chair)in
Co-investors+ND CapitalARCH Venture PartnersForbionVenrockFast Track InitiativeNextech Invest+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 3
2 IPOs · 1 acquisitions · showing 2QuanterixNASDAQ: QTRXGinkgo BioworksNYSE: DNA
Portfolio news
latest coverage across their companiesVizgen · intelligence360.news · Feb 2, 2026
Flywheel Exchange, Inc. · thesaasnews.com · Jan 12, 2026
Frequently asked questions
- How many investments has Novalis LifeSciences made?
- Novalis LifeSciences has 27 tracked investments, 3 of which have exited, including 3 dated in the last 24 months.
- What stage does Novalis LifeSciences invest at?
- Novalis LifeSciences invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does Novalis LifeSciences focus on?
- Novalis LifeSciences focuses on Biotech, Healthtech, Medical Devices.
- Where is Novalis LifeSciences located?
- Novalis LifeSciences is headquartered in Portsmouth, US.
- Does Novalis LifeSciences lead rounds?
- Novalis LifeSciences has led 7 of the 8 rounds where its role is on record.
- Who does Novalis LifeSciences co-invest with?
- Novalis LifeSciences most often shares deals with DYDX Capital, iSelect Fund, 8VC, among 25 tracked co-investors.
Images
Similar investors
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Sofinnova is an investment firm focused on the life sciences and biotechnology sector, partnering with companies from inception through drug development, regulatory approval, company building, and IPO.
Black Opal Ventures is a venture capital firm founded in 2021 by Tara Bishop and Eileen Tanghal, investing at the intersection of technology and healthcare.